News & Events
-
-
Press Announcements
-
-
Sign up to receive FDA Press Releases.
Note: Some links in press announcements are no longer active, but remain for archival purposes. For more information, contact the FDA's Press Office at 301-796-4540.
-
April 2012
- April 18, 2012 - U.S. Marshals seize ultrasound gel product at a New Jersey company
- April 13, 2012 - La compañía Moon Marine USA Corporation retira voluntariamente del mercado el producto de atún de aleta amarilla crudo congelado
- April 13, 2012 - Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product
- April 11, 2012 - Dept. of Justice enters consent decree with California seafood processor
- April 11, 2012 - La FDA toma medidas para proteger la salud pública
- April 11, 2012 - FDA takes steps to protect public health
- April 10, 2012 - FDA approves imaging drug Amyvid
- April 09, 2012 - La FDA dicta decreto por consentimiento con productor de queso debido a contaminación por Listeria
- April 09, 2012 - FDA enters consent decree with cheese producer due to Listeria contamination
- April 09, 2012 - FDA announces plans to pilot end-stage kidney disease technology in new program
- April 05, 2012 - La FDA advierte a los consumidores a no comer galletas y pan tostado de marca Crispy fabricado por TWI Foods Inc., Ontario, Canadá
- April 05, 2012 - FDA warns consumers not to eat Crispy brand cookies and rusk manufactured by TWI Foods Inc., Ontario, Canada
-
March 2012
- March 30, 2012 - El gobierno del Presidente Obama toma medidas para enfrentar la epidemia de consumo de tabaco
- March 30, 2012 - Obama administration takes action to address tobacco epidemic
- March 29, 2012 - U.S. Marshals seize unapproved and misbranded drug products at Missouri distributor
- March 29, 2012 - FDA pursues enforcement action against California fish processor
- March 29, 2012 - FDA to discuss risks and benefits of metal-on-metal hip replacements
- March 27, 2012 - FDA approves additional blood test for viruses linked to leukemia, neurologic diseases
- March 27, 2012 - FDA approves Omontys to treat anemia in adult patients on dialysis
- March 27, 2012 - New FDA guidance on considerations used in device approval, de novo decisions
- March 22, 2012 - FDA approves LINX Reflux Management System to treat gastroesophageal reflux disease
- March 19, 2012 - FDA approves first Boniva generics to treat or prevent osteoporosis
- March 16, 2012 - FDA proposes lower risk classification for certain tuberculosis tests
- March 14, 2012 - FDA approves first generic Lexapro to treat depression and anxiety disorder
- March 09, 2012 - La FDA aprueba nuevos implantes de seno rellenos de gel de silicona
- March 09, 2012 - FDA approves new silicone gel-filled breast implant
- March 09, 2012 - FDA approves first cell-based product to treat oral mucogingival conditions in adults
- March 08, 2012 - FDA Commissioner Margaret A. Hamburg's Statement on the Surgeon General's Report
- March 06, 2012 - FDA approves Surfaxin to prevent breathing disorder in premature infants
- March 06, 2012 - FDA issues warning letter to makers of AeroShot “caffeine inhaler”
- March 01, 2012 - FDA approves two new pancreatic enzyme products to aid food digestion
-
February 2012
- February 29, 2012 - FDA approves first quadrivalent vaccine to prevent seasonal influenza
- February 28, 2012 - FDA reaches $1 million settlement with Pennsylvania medical device firm
- February 28, 2012 - La FDA anuncia modificaciones relacionadas con la seguridad en las indicaciones de algunos medicamentos que reducen el colesterol
- February 28, 2012 - FDA announces safety changes in labeling for some cholesterol-lowering drugs
- February 24, 2012 - FDA approves first Helicobacter pylori breath test for children
- February 22, 2012 - Federal government gains permanent injunction against raw milk producer
- February 21, 2012 - FDA acts to bolster supply of critically needed cancer drugs
- February 17, 2012 - FDA approves Korlym for patients with endogenous Cushing’s syndrome
- February 14, 2012 - FDA approves Zioptan to treat elevated eye pressure
- February 13, 2012 - FDA seeks $4.5 billion to support medical product development, protect patients and ensure safety of the food supply
- February 13, 2012 - New Jersey company agrees to halt production of unapproved dental devices
- February 09, 2012 - FDA investigating illegal online sale of handheld dental X-ray units
- February 09, 2012 - FDA issues draft guidance on biosimilar product development
- February 01, 2012 - FDA and industry reach agreement in principle on medical device user fees
-
January 2012
- January 31, 2012 - FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer
- January 31, 2012 - FDA approves Kalydeco to treat rare form of cystic fibrosis
- January 31, 2012 - FDA takes action against New York cheese manufacturer
- January 30, 2012 - FDA approves new treatment for most common type of skin cancer
- January 27, 2012 - FDA approves Inlyta to treat patients with a type of advanced kidney cancer
-
-
-
-